The nurse is caring for a patient receiving intravesical bladder chemotherapy. The nurse should monitor for which adverse effect?
Correct Answer: C
Rationale: Intravesical chemo (e.g., BCG for bladder cancer) targets the bladder lining directly hematuria (blood in urine) is the biggie to watch, signaling irritation or tumor breakdown. It's local, not systemic, so nausea and alopecia whole-body effects from IV chemo don't fit. Xerostomia (dry mouth) might tag along with systemic agents hitting salivary glands, not this route. Nurses track hematuria here because it's the bladder's cry for help, a common, expected reaction to drugs bathing the mucosa. In oncology, knowing delivery matters intravesical skips the bloodstream, keeping side effects bladder-focused, critical for patient comfort and spotting complications early.